About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,885 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,885 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 2141-2160 of 10,885 trials

CompletedTrial of PI-88 With Dacarbazine in Patients With Metastatic MelanomaThe aim of the study is to compare the safety and effectiveness of a new drug called PI-88, when used in combination with an approved chemotherapy drug called dacarbazine, in the…NCT00130442·Tucson, Arizona and 11 others CompletedRandomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent RestenosisThe objective of this study is to evaluate the safety and effectiveness of the TAXUS Express2 Paclitaxel-Eluting Coronary Stent System as compared to brachytherapy in patients…NCT00287573·Birmingham, Alabama and 41 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

RecruitingTLN-372 in Advanced KRAS Mutant Solid TumorsThe primary purpose of this study is to evaluate the safety, pharmacokinetics, and anti-tumor activity of TLN-372 as a single agent and in combination with other anti-tumor…NCT07204340·Birmingham, Alabama and 10 others

TerminatedThis SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.The purpose of this study is to obtain archived tumor tissue or pre-existing antigen expression data from patients with Head and Neck, Cervical, Melanoma and Non-Small Cell Lung…NCT05061940·Scottsdale, Arizona and 2 others

TerminatedA Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid LeukemiaGDX012 is a novel cell therapy developed for the treatment of certain types of cancer, including Acute Myeloid Leukemia (AML).NCT05886491·Birmingham, Alabama and 10 others

CompletedRelating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic ProfileThe primary objective of this observational study is to identify the molecular profiles and clinical characteristics that define subsets of myeloma patients during the course of…NCT01454297·Scottsdale, Arizona and 72 others

RecruitingA Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast CancerThe goal of this clinical study is to learn more about the study drug sacituzumab govitecan-hziy (SG) given at an alternative dose and schedule, in participants with…NCT06926920·Los Angeles, California and 15 others

CompletedNivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung CancerThe purpose of part 1 of this study is to determine the objective response rate (ORR) in stage IV NSCLC subjects treated with nivolumab in combination with ipilimumab as first…NCT02659059·San Diego, California and 31 others

CompletedA Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia RepairThis study will evaluate the safety and efficacy of two different dose regimens (12 milligrams \[mg\] and 24 mg) of IV MOA-728 versus placebo in shortening the time to return of…NCT00528970·Benton, Arkansas and 105 others

TerminatedA Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLCA phase 1, first-in-human, open-label study to evaluate the safety, tolerability, PK, and efficacy of the novel ALK inhibitor TPX-0131 in pretreated subjects with ALK+ advanced or…NCT04849273·Orange, California and 14 others

CompletedReal-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)The primary objective of the study is to evaluate relapse activity, as measured by the proportion of participants relapsed at 12 months, in participants with relapsing-remitting…NCT02159573·Birmingham, Alabama and 42 others

CompletedA Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy PatientsA prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open-label arm for…NCT02290873·Mobile, Alabama and 12 others

CompletedGolimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)The purpose of this study is to evaluate the efficacy and safety of switching rheumatoid arthritis (RA) participants who have an inadequate response to their current treatment…NCT01004432·Birmingham, Alabama and 116 others

TerminatedStudy to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry EyePrimary Objective \- To assess the proportion of patients with Sjögren's dry eye who demonstrate impaired corneal sensitivity.NCT06411132·Bakersfield, California and 14 others

CompletedA 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) Remigromig (EYE103) in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)EYE103-101 is a 2-part study assessing safety and preliminary efficacy of remigromig (EYE103) in patients with diabetic macular edema (DME) given as monotherapy or neovascular…NCT05919693·Phoenix, Arizona and 31 others

RecruitingMammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesThe FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry.NCT03053193·Birmingham, Alabama and 133 others

TerminatedTrilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)This was a study to investigate the potential clinical benefit of trilaciclib (G1T28) in preserving the bone marrow and the immune system, and enhancing chemotherapy antitumor…NCT02978716·Tucson, Arizona and 53 others

Active not recruitingPre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV InfectionThe goal of this study is to evaluate the efficacy of the study drugs, lenacapavir (LEN) in preventing HIV infection, in participants ≥ 16 years of age who have condomless…NCT04925752·Birmingham, Alabama and 92 others

CompletedStudy of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2)The purpose of this study is to evaluate desmoteplase (which is a manufactured protein derived from the saliva of the vampire bat) in dissolving clots that are blocking the flow…NCT00111852·Birmingham, Alabama and 43 others

CompletedWithdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With MemantineThe purpose of this randomized withdrawal study is to evaluate the safety, tolerability, and efficacy of memantine compared with placebo in pediatric patients with autism…NCT01592747·Dothan, Alabama and 93 others

PreviousPage 108 of 545Next

Diabetes

in Nashville

Heart Diseasein Nashville